Cargando…
Moving towards more patient-centred clinical trials in IBD
Declining recruitment rates in inflammatory bowel disease (IBD) trials have resulted in calls to modify the conduct of trials in IBD in order to make them more efficient and patient centred. Here, we propose a number of potential modifications.
Autores principales: | Noor, Nurulamin M., Parkes, Miles, Raine, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312205/ https://www.ncbi.nlm.nih.gov/pubmed/34312526 http://dx.doi.org/10.1038/s41575-021-00500-x |
Ejemplares similares
-
Innovations to improve the efficiency of phase II IBD clinical trials
por: Noor, Nurulamin M., et al.
Publicado: (2023) -
SARS-CoV-2 vaccination in IBD: more pros than cons
por: D’Amico, Ferdinando, et al.
Publicado: (2021) -
Editorial: Current trends and future management of IBD
por: Estevinho, María Manuela, et al.
Publicado: (2023) -
A blood-based prognostic biomarker in IBD
por: Biasci, Daniele, et al.
Publicado: (2019) -
Management of IBD during the COVID-19 outbreak: resetting clinical priorities
por: Danese, Silvio, et al.
Publicado: (2020)